Organization
ASST Spedali Civili - Brescia
4 abstracts
Abstract
Results of MOLTO, a multicenter, open label, phase II clinical trial evaluating venetoclax, atezolizumab and obinutuzumab combination in Richter syndrome.Org: Niguarda Cancer Center, Laboratory of Experimental Hematology, Clinic of Hematology, Ente Ospedaliero Cantonale, Universita’ della Svizzera italiana,
Abstract
Immune checkpoint inhibitor in high-risk oral potentially malignant disorders (IMPEDE study): An interim analysis on safety.Org: University of Brescia, ASST Spedali Civili - Brescia, Angelo Nocivelli Institute of Molecular Medicine, University of Brescia and ASST-Spedali Civili, ASST-Spedali Civili of Brescia,
Abstract
Profile of toxicities and quality of life in long-term survivors treated with immunotherapy: A prospective cross sectional trial.Org: University of Brescia, ASST Spedali Civili - Brescia, University Hospital of Parma, University of Pisa, Pisa, Italy, ATC Innovation Lab,
Abstract
ANTI-TH/TO POSITIVITY IN SYSTEMIC SCLEROSIS: ANALYSIS OF PULMONARY INVOLVEMENT, ORGAN DAMAGE ACCRUAL AND MORTALITY IN AN ITALIAN MONOCENTRIC COHORTOrg: ASST Spedali Civili - Brescia, University of Brescia, Rheumatology and Clinical Immunology, Biomedical Engineering, Vascular diseases, University Medical Center, Groningen, Netherlands,